Trial Profile
Absorb BVS in diabetic patients
Status:
Planning
Phase of Trial:
Phase IV
Latest Information Update: 14 Feb 2013
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms ABSORB Diabetics
- Sponsors Abbott Vascular
- 14 Feb 2013 New trial record